Cyagen and Taconic Join Forces to Expand Access to Genetically Engineered Mouse Models for Preclinical Research

Cyagen and Taconic Partnered to Receive Permission for Preclinical Studies of Mouse and Rat Models

Announcement

Cyagen Biosciences, a leading AI-powered CRO company, a pioneer in cell models for research, and custom genetically engineered animals, collaborated with Taconic Biosciences, a well-known provider of specific disease rodent model solutions and suitable services. This smart partnership was initiated from both ends to enable preclinical researchers seamless and extensive access to Cyagen’s huge library of over 16,000 genetically engineered mouse models. Taconic has been a reliable provider of researchers with robust models produced under the industry-guided biosecurity standards and animal welfare, whereas Cyagen’s remarkable and reliable portfolio of Cko/ko models enables unmatched speed and affordability that leverages exploratory factors around the huge biomedical sciences.

Cyagen’s Library and its New Distributor, Taconic

Cyagen’s library of genetically engineered mouse models is created with the help of AI-assisted potency and state-of-the-art methods. The library of conditional knockout, cre-recombinase expressing, reporter, and knockout models rules the space of disease, potential drug targets, and physiological processes. These animal models are complicated to discover disease modeling, gene functions, and  , including drug safety inspection.

Taconic will be a distributor to Cyagen’s animal model library in Europe and North America, merging Cyagen’s massive library with Taconic’s excellent colony management services and animal production. The scientist in preclinical drug discovery and basic research will have access to these models without any fear or hesitation, supported by the required expertise in production and model generation and use in preclinical studies and drug discovery.

Statements from Industry Experts

CEO of Taconic, Mike Garrett, said, “An addition of more than 200 cre (inducible) models and a broad catalogue of gene edited mouse conditional knockout (cko) and knockout (ko) models in our existing library of approximately 4,500 mouse models, we’re extending our major solutions to support the needs of biomedical researchers.”

Founder and President of Cyagen, Lance Han, said, “For years, we’ve been successfully using the genetic tools to tackle rare diseases, metabolic disorders, immune-oncology, and neurodegeneration. I feel proud to announce our partnership with Taconic. This will extend global access to our models, mainly for researchers in every disease area. We will together introduce the robust models closely to global customers by aligning Cyagen’s innovation in genetic engineering and remarkable quality and health standards, and the worldwide reach of Taconics. This partnership encourages scientists to change discovery into impact, quickly.”